Final Decision: HOLD

Reason: The recent news sentiment around DRREDDY is neutral to mildly positive, with the company's stock split and launch of new drugs receiving positive attention. However, margin pressures and uncertain Q2 earnings growth are concerns, making it a hold decision for now.